Juan Pablo Alderuccio

43PUBLICATIONS
202CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Sep 18, 2026
RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas.

|Mar 17, 2026
Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Leon D Kaulen, Lakshmi Nayak, Philipp Karschnia

|Jan 06, 2026
Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma.

Juan Pablo Alderuccio, Diva Baggio, Sunwoo Han

|Sep 03, 2025
Multi-Institutional Study of ALK-Positive Large B-Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies.

Suheil Albert Atallah-Yunes, Chijioke C Nze, Rebecca L King

|Jul 16, 2025
Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial.

Russ A Kuker, Juan P Alderuccio, Sunwoo Han

|Jul 15, 2025
The treatment of marginal zone lymphoma.

Juan Pablo Alderuccio, Ariela Noy

Pageof 8

Frequent Collaborators

27 joint publications

Izidore S Lossos

7 joint publications

Brad S Kahl

6 joint publications

Narendranath Epperla

5 joint publications

Thomas M Habermann